Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Not another 70 years: Republicans seek to douse Queen Elizabeth celebrations

WorldJan 10, 2022 12:56PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Britain's Queen Elizabeth attends the opening ceremony of the sixth session of the Senedd in Cardiff, Britain October 14, 2021. Jacob King/Pool via REUTERS

(Repeats with no change to text)

LONDON (Reuters) -British republicans said on Monday they would launch a campaign to end the monarchy in the run-up to celebrations to mark Queen Elizabeth's 70 years on the throne.

Elizabeth, 95, the world's oldest and longest-reigning monarch, will mark her seventh decade as sovereign next month and on Monday Buckingham Palace detailed plans for four days of celebrations for her Platinum Jubilee in June.

But anti-monarchy group Republic used the occasion to say it would begin a "Not Another 70" campaign to call for an end to the historic institution.

"While a vocal minority will want to celebrate the queen's seventy year reign, we must all start looking to the future. The prospect of King Charles is not a happy one, and there is a good, democratic alternative on offer," Republic's Graham (NYSE:GHM) Smith said.

"It's time to have a serious debate about our constitution, accept that Charles is not the best the country has to offer, and that as a nation we are quite capable of choosing our head of state."

Polls indicate the vast majority of people in Britain support the monarchy and the queen herself is hugely popular. But there is not as much support for her eldest son and heir Charles, and surveys suggest there is growing republican sentiment among younger Britons.

Not another 70 years: Republicans seek to douse Queen Elizabeth celebrations
 

Related Articles

U.S. says use of Pfizer's COVID-19 antiviral up 315%
U.S. says use of Pfizer's COVID-19 antiviral up 315% By Reuters - May 17, 2022

By Ahmed Aboulenein WASHINGTON (Reuters) -Use of Pfizer Inc (NYSE:PFE)'s COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Department...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email